Eppendorf CryoCube® F440 ULT freezers now all-green

Hamburg -- Eppendorf continues to follow the path of sustainability by re-designing the 400 L ULT freezer class. The well-known standard-sized ultra-low temperature (ULT) freezer is now completely equipped with future-proof green cooling liquids and green insulation foam as well as better performance. By combining longevity and quality with sustainability aspects, the CryoCube F440 series [...]

H.E.L signs distribution agreement with Particular Sciences

Particular Sciences to distribute H.E.L’s product portfolio in Eire and Northern Ireland. London, UK: H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimization, safety, and scale-up, today announced a distribution agreement with Particular Sciences Ltd, Dublin. Under this agreement, Particular Sciences become the exclusive distributor of H.E.L’s products in Eire [...]

Endress+Hauser and Hahn-Schickard create joint venture

Endress+Hauser BioSense to develop equipment and methods for fast molecular analyses Increased safety in food production and other process applications is the declared aim of the joint venture between Endress+Hauser and Hahn-Schickard. To this end, both partners have established Endress+Hauser BioSense GmbH based in Freiburg, Germany. Its aim is to enable rapid, on-site molecular analyses [...]

Congenica Receives CE Mark for Genomic Analysis Software

Cambridge, United Kingdom – Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, today announces that its genomic interpretation software is now CE marked under the In Vitro Diagnostics Directive (98/79/EC). With the In Vitro Diagnostic (IVD) designation, Congenica’s clinical decision support platform can make the transition [...]

Shimadzu Europa – Jürgen Semmler takes over as new Managing Director

Future development and growth trends Shimadzu, one of the world leaders in analytical instrumentation, has appointed Jürgen Semmler as the new Managing Director of its European organization from July 1st, 2021. Previously head of Shimadzu Deutschland, he succeeds Jürgen Kwass, who led Shimadzu Europa from 2003 to the present and is now retiring. Semmler and [...]

Twist Bioscience Now Shipping Synthetic RNA Positive Controls for Delta (B.1.617.2) SARS-CoV-2 Variant for Development of Accurate Diagnostic Tests

SOUTH SAN FRANCISCO, Calif.-- Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has started shipping its synthetic RNA reference controls for the SARS-CoV-2 Delta (B.1.617.2) and B.1.617.3 variants first identified in India and spreading rapidly worldwide. “Just [...]

Agilent Technologies Celebrates More than 20 Years of Sustainable Progress

2020 CSR report highlights commitment to employees, customers, partners, and the global community SANTA CLARA, Calif. --  Agilent Technologies, Inc. (NYSE: A) today issued its 21st annual Corporate Social Responsibility (CSR) report. The report highlights the company’s progress in critical environmental, social and governance (ESG) areas as well its commitment to employees, customers, partners, and the global [...]

Cytek Biosciences Announces Pricing of Its Initial Public Offering

FREMONT, Calif. -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, announced today the pricing of its initial public offering of an aggregate of 16,749,330 shares of its common stock at a price to the public of $17.00 per share. The gross proceeds to Cytek from the offering, [...]

908 Devices and Transcenta’s Joint Innovation Partnership Accelerates Biopharma Development

908 Devices (NASDAQ:MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced outcomes of its joint innovation partnership with Transcenta, a global biotherapeutics company. Transcenta has implemented 908 Devices’ technologies within its Process and Product Development Center and Manufacturing Facility in Hangzhou, China to facilitate their biopharma analytical workflows [...]

INmune Bio acquires LUMICKS’ z-Movi® Cell Avidity Analyzer to accelerate the development of its NK cell platform for cancer treatments

AMSTERDAM -- LUMICKS, a leading next generation life science tools company renowned for its innovative platforms for Dynamic Single-Molecule and Cell Avidity analysis, has installed its ground-breaking z-Movi® Cell Avidity Analyzer at INmune Bio (NASDAQ: INMB). INmune Bio is a clinical stage biotechnology company developing new therapies that modulate the innate immune system to treat cancer [...]

Access IBO on Knowledge Center